NASDAQ

ABVC BioPharma, Inc. (ABVC)

676 Thanks from members

ABVC BioPharma, Inc. (ABVC) exhibits deeply strained financial fundamentals, highlighted by a severe going-concern risk, a cash balance plummeting to roughly $32K, and recent restatements, contrasting with modest institutional interest and a speculative market capitalization near $46.8M.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →